Patient P-01753

Synthetic patientNBL-101 · Day 90 · 55–64 · F · baseline S03Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

29%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S03

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Nutritional resilience-9
GI instability+6
Inflammatory activity+5
Toxicity+4
Treatment adherence+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

29.9/100

improving · -16.2 vs previous 14 d

Toxicity

Blood

24.3/100

worsening · +4.0 vs previous 14 d

Sleep quality

Wearable

54.5/100

improving · +8.1 vs previous 14 d

Energy level

Daily log

4.6/10

improving · +0.9 vs previous 14 d

Stress level

Daily log

4.4/10

improving · -0.7 vs previous 14 d

Steps

Wearable

9,182

improving · +464 vs previous 14 d

Adherence

Companion

91.6 %

stable · +1.9 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 61 from the failing basin, 26 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Insoluble fibre
+1no signal · 19%
Alcohol
+0.8no signal · 15%
Simple carbohydrates
+0.6no signal · 15%
Spicy / capsaicin
+0.5no signal · 15%
Dietary fat load
-0.4no signal · 15%
Histamine load
+0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑75
- DNACYP2D6 poor metabolizer → higher exposure
- DNADPYD *2A → slower clearance
Inflammatory signalling ↑45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
Autonomic recovery ↑45
- WearableResting HR 76 bpm
- WearableShort sleep window
Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
DPYD *2A heterozygous
Slower drug clearance
CYP2D6 Poor metabolizer
Higher exposure at standard dose
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3.7 · butyrate capacity 79/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 66 ms
Sleep: 6.1 h
Steps: 8,893
Resting HR: 73 bpm

Daily log: GI score 30, nutritional resilience 58, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01571	47%	S13	SC-12	improved	57
P-01724	41%	S10	DT-01	improved	63
P-01861	38%	S12	HY-01	improved	47
P-01455	37%	S01	GI-04	improved	61
P-01555	36%	S06	GI-04	improved	56
P-01342	35%	S11	DT-01	improved	48
P-01430	35%	S05	CR-01	improved	54
P-01752	35%	S20	DT-01	improved	50
P-01321	34%	S12	GI-04	improved	53
P-01374	34%	S08	HY-01	improved	49
P-01804	33%	S19	AD-05	improved	61
P-01593	32%	S10	HY-01	improved	56